Shuttle Pharmaceuticals Holdings (SHPH) said in a filing with the US Securities and Exchange Commission that it is offering common shares, pre-funded warrants to buy shares, and warrants to purchase shares.
The company did not disclose the terms of the offering including pricing and number of shares, pre-funded warrants and warrants.
Shuttle plans to use the net proceeds from the offering to fund trials of product candidates, and pay $2.3 million owed to clinical research organization Theradex Systems.
Shares of Shuttle Pharmaceuticals were down nearly 6% in recent trading.
Price: 1.53, Change: -0.09, Percent Change: -5.68